{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:41:46Z","timestamp":1793320906453,"version":"4.5.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2015MPESJS_004"],"award-info":[{"award-number":["2015MPESJS_004"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017FM74HK"],"award-info":[{"award-number":["2017FM74HK"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005970","name":"Deutsche Stiftung f\u00fcr Herzforschung","doi-asserted-by":"publisher","award":["[F-43-16]"],"award-info":[{"award-number":["[F-43-16]"]}],"id":[{"id":"10.13039\/501100005970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11154-019-09533-9","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T19:04:28Z","timestamp":1576263868000},"page":"399-406","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Gut microbiome and cardiometabolic risk"],"prefix":"10.1007","volume":"20","author":[{"given":"Ben Arpad","family":"Kappel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4989-5194","authenticated-orcid":false,"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,14]]},"reference":[{"key":"9533_CR1","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019.","journal-title":"Nat Rev Dis Primers"},{"issue":"16","key":"9533_CR2","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WHW Tang","year":"2019","unstructured":"Tang WHW, B\u00e4ckhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(16):2089\u2013105.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"9533_CR3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00592-019-01315-8","volume":"56","author":"M Federici","year":"2019","unstructured":"Federici M. Our second genome and the impact on metabolic disorders: why gut microbiome is an important player in diabetes and associated abnormalities. Acta Diabetol. 2019;56(5):491\u20132.","journal-title":"Acta Diabetol"},{"issue":"9","key":"9533_CR4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s40618-019-01022-9","volume":"42","author":"M Federici","year":"2019","unstructured":"Federici M. Gut microbiome and microbial metabolites: a new system affecting metabolic disorders. J Endocrinol Investig. 2019;42(9):1011\u20138.","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"9533_CR5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00059-019-4791-x","volume":"44","author":"BA Kappel","year":"2019","unstructured":"Kappel BA, Lehrke M. Microbiome, diabetes and heart: a novel link? Herz. 2019;44(3):223\u201330.","journal-title":"Herz."},{"issue":"2","key":"9533_CR6","doi-asserted-by":"publisher","first-page":"283-295.e8","DOI":"10.1016\/j.chom.2019.07.008","volume":"26","author":"Braden T. Tierney","year":"2019","unstructured":"Tierney BT, Yang Z, Luber JM, Beaudin M, Wibowo MC, Baek C, et al. The landscape of genetic content in the gut and Oral human microbiome. Cell Host Microbe. 2019. https:\/\/doi.org\/10.1016\/j.chom.2019.07.008.","journal-title":"Cell Host & Microbe"},{"issue":"6086","key":"9533_CR7","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262\u20137.","journal-title":"Science."},{"issue":"5","key":"9533_CR8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.cmet.2012.10.007","volume":"16","author":"E Holmes","year":"2012","unstructured":"Holmes E, Li JV, Marchesi JR, Nicholson JK. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 2012;16(5):559\u201364.","journal-title":"Cell Metab"},{"issue":"7122","key":"9533_CR9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027\u201331.","journal-title":"Nature."},{"issue":"6150","key":"9533_CR10","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","volume":"341","author":"VK Ridaura","year":"2013","unstructured":"Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214.","journal-title":"Science"},{"issue":"10","key":"9533_CR11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/nm.4185","volume":"22","author":"BO Schroeder","year":"2016","unstructured":"Schroeder BO, B\u00e4ckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079\u201389.","journal-title":"Nat Med"},{"key":"9533_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0061-2","volume-title":"You are what you eat: diet, health and the gut microbiotaNat","author":"N Zmora","year":"2019","unstructured":"Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiotaNat. Hepatol: Rev. Gastroenterol; 2019. https:\/\/doi.org\/10.1038\/s41575-018-0061-2. You are what you eat: diet, health and the gut microbiota"},{"issue":"5","key":"9533_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrgastro.2017.29","volume":"14","author":"Eamonn M. M. Quigley","year":"2017","unstructured":"Quigley EMM. Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet? Nat Rev Gastroenterol Hepatol. 2017. https:\/\/doi.org\/10.1038\/nrgastro.2017.29 Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"9533_CR14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","volume":"528","author":"K Forslund","year":"2015","unstructured":"Forslund K, Hildebrand F, Nielsen T, Falony G, Le Chatelier E, Sunagawa S, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528:262\u20136.","journal-title":"Nature"},{"key":"9533_CR15","doi-asserted-by":"publisher","unstructured":"Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2019:1\u201315. https:\/\/doi.org\/10.1038\/s41577-019-0198-4.","DOI":"10.1038\/s41577-019-0198-4"},{"issue":"5","key":"9533_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41574-019-0156-z","volume":"15","author":"EE Canfora","year":"2019","unstructured":"Canfora EE, Meex RCR, Venema K, Blaak EE. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2019;15(5):261\u201373.","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"9533_CR17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41591-019-0414-6","volume":"25","author":"SM Sch\u00fcssler-Fiorenza Rose","year":"2019","unstructured":"Sch\u00fcssler-Fiorenza Rose SM, Contrepois K, Moneghetti KJ, Zhou W, Mishra T, Mataraso S, et al. A longitudinal big data approach for precision health. Nat Med. 2019;25(5):792\u2013804.","journal-title":"Nat Med"},{"key":"9533_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41587-019-0233-9","volume":"37","author":"T Wilmanski","year":"2019","unstructured":"Wilmanski T, Rappaport N, Earls JC, Magis AT, Manor O, Lovejoy J, et al. Blood metabolome predicts gut microbiome \u03b1-diversity in humans. Nat Biotechnol. 2019;37:1217\u201328. https:\/\/doi.org\/10.1038\/s41587-019-0233-9.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"9533_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00592-012-0410-5","volume":"50","author":"M Serino","year":"2013","unstructured":"Serino M, Fern\u00e1ndez-Real JM, Garc\u00eda-Fuentes E, Queipo-Ortu\u00f1o M, Moreno-Navarrete JM, S\u00e1nchez A, et al. The gut microbiota profile is associated with insulin action in humans. Acta Diabetol. 2013;50(5):753\u201361. https:\/\/doi.org\/10.1007\/s00592-012-0410-5 Epub 2012 Jun 19.","journal-title":"Acta Diabetol"},{"issue":"12","key":"9533_CR20","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1007\/s00125-011-2329-8","volume":"54","author":"J Amar","year":"2011","unstructured":"Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S, et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia. 2011;54(12):3055\u201361.","journal-title":"Diabetologia."},{"issue":"6","key":"9533_CR21","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/hep.28829","volume":"64","author":"B Lelouvier","year":"2016","unstructured":"Lelouvier B, Servant F, Pa\u00efss\u00e9 S, Brunet AC, Benyahya S, Serino M, et al. Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis. Hepatology. 2016;64(6):2015\u201327.","journal-title":"Hepatology."},{"issue":"Suppl 1","key":"9533_CR22","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1011383107","volume":"108","author":"O Koren","year":"2011","unstructured":"Koren O, Spor A, Felin J, F\u00e5k F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4592\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9533_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.atherosclerosis.2017.06.016","volume":"263","author":"A Lindskog Jonsson","year":"2017","unstructured":"Lindskog Jonsson A, H\u00e5llenius FF, Akrami R, Johansson E, Wester P, Arnerl\u00f6v C, et al. Bacterial profile in human atherosclerotic plaques. Atherosclerosis. 2017;263:177\u201383.","journal-title":"Atherosclerosis."},{"issue":"2","key":"9533_CR24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.atherosclerosis.2015.10.097","volume":"243","author":"F F\u00e5k","year":"2015","unstructured":"F\u00e5k F, Tremaroli V, Bergstr\u00f6m G, B\u00e4ckhed F. Oral microbiota in patients with atherosclerosis. Atherosclerosis. 2015;243(2):573\u20138.","journal-title":"Atherosclerosis."},{"issue":"7","key":"9533_CR25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","volume":"24","author":"L Hoyles","year":"2018","unstructured":"Hoyles L, Fern\u00e1ndez-Real JM, Federici M, Serino M, Abbott J, Charpentier J, et al. Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women. Nat Med. 2018;24(7):1070\u201380.","journal-title":"Nat Med"},{"key":"9533_CR26","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ncomms2266","volume":"3","author":"FH Karlsson","year":"2012","unstructured":"Karlsson FH, F\u00e5k F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245.","journal-title":"Nat Commun"},{"issue":"1","key":"9533_CR27","doi-asserted-by":"crossref","first-page":"12918","DOI":"10.1038\/s41598-019-49452-y","volume":"9","author":"LJ Wilkins","year":"2019","unstructured":"Wilkins LJ, Monga M, Miller AW. Defining Dysbiosis for a cluster of chronic diseases. Sci Rep. 2019;9(1):12918.","journal-title":"Sci Rep"},{"issue":"7","key":"9533_CR28","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761\u201372 Epub 2007 Apr 24.","journal-title":"Diabetes"},{"issue":"11","key":"9533_CR29","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1007\/s00125-013-3015-9","volume":"56","author":"JM Moreno-Navarrete","year":"2013","unstructured":"Moreno-Navarrete JM, Escot\u00e9 X, Ortega F, Serino M, Campbell M, Michalski MC, et al. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia. 2013;56(11):2524\u201337. https:\/\/doi.org\/10.1007\/s00125-013-3015-9.","journal-title":"Diabetologia"},{"issue":"9","key":"9533_CR30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.molmet.2016.05.016","volume":"5","author":"R Burcelin","year":"2016","unstructured":"Burcelin R. Gut microbiota and immune crosstalk in metabolic disease. Mol Metab. 2016;5(9):771\u201381.","journal-title":"Mol Metab."},{"issue":"5","key":"9533_CR31","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.immuni.2018.09.011","volume":"49","author":"AR Fatkhullina","year":"2018","unstructured":"Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, et al. An Interleukin-23-Interleukin-22 Axis RegulatesIntestinal microbial homeostasis to protect from diet-induced atherosclerosis. Immunity. 2018;49(5):943\u201357.","journal-title":"Immunity"},{"issue":"3","key":"9533_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"Ivaylo I. Ivanov","year":"2009","unstructured":"Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous Bacteria. Cell. 2009. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033.","journal-title":"Cell"},{"key":"9533_CR33","doi-asserted-by":"publisher","unstructured":"Karbach SH, Sch\u00f6nfelder T, Brand\u00e3o I, Wilms E, H\u00f6rmann N, J\u00e4ckel S, et al. Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction. J Am Heart Assoc. 2016;5. https:\/\/doi.org\/10.1161\/JAHA.116.003698.","DOI":"10.1161\/JAHA.116.003698"},{"key":"9533_CR34","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","volume":"551","author":"N Wilck","year":"2017","unstructured":"Wilck N, Matus MG, Kearney SM, Olesen SW, Forslund K, Bartolomaeus H, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature. 2017;551:585\u20139.","journal-title":"Nature"},{"issue":"16","key":"9533_CR35","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00018-017-2509-x","volume":"74","author":"GA Weiss","year":"2017","unstructured":"Weiss GA, Hennet T. Mechanisms and consequences of intestinal dysbiosis. Cell Mol Life Sci. 2017;74(16):2959\u201377.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"9533_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"I Rowland","year":"2018","unstructured":"Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57(1):1\u201324.","journal-title":"Eur J Nutr"},{"issue":"D1","key":"9533_CR37","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, V\u00e1zquez-Fresno R, et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 2018;46(D1):D608\u201317.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"9533_CR38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00592-019-01312-x","volume":"56","author":"MBH Abdul Rahim","year":"2019","unstructured":"Abdul Rahim MBH, Chilloux J, Martinez-Gili L, Neves AL, Myridakis A, Gooderham N, et al. Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles. Acta Diabetol. 2019;56(5):493\u2013500.","journal-title":"Acta Diabetol"},{"issue":"1","key":"9533_CR39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.atherosclerosis.2011.06.001","volume":"219","author":"PM Lepper","year":"2011","unstructured":"Lepper PM, Kleber ME, Grammer TB, Hoffmann K, Dietz S, Winkelmann BR, et al. Lipopolysaccharide-binding protein (LBP) is associated with total and cardiovascular mortality in individuals with or without stable coronary artery disease--results from the Ludwigshafen risk and cardiovascular health study (LURIC). Atherosclerosis. 2011;219(1):291\u20137.","journal-title":"Atherosclerosis."},{"issue":"2","key":"9533_CR40","doi-asserted-by":"crossref","first-page":"E371","DOI":"10.1152\/ajpendo.00507.2007","volume":"294","author":"R Krogh-Madsen","year":"2008","unstructured":"Krogh-Madsen R, Plomgaard P, Akerstrom T, M\u00f8ller K, Schmitz O, Pedersen BK. Effect of short-term intralipid infusion on the immune response during low-dosebendotoxemia in humans. Am J Physiol Endocrinol Metab. 2008;294(2):E371\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"9533_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/08830185.2015.1087518","volume":"35","author":"A Gnauck","year":"2016","unstructured":"Gnauck A, Lentle RG, Kruger MC. The characteristics and function of bacterial lipopolysaccharides and their Endotoxic potential in humans. Int Rev Immunol. 2016;35(3):189\u2013218.","journal-title":"Int Rev Immunol"},{"issue":"7","key":"9533_CR42","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","volume":"34","author":"CJ Wiedermann","year":"1999","unstructured":"Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhollenzer F, et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol. 1999;34(7):1975\u201381.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"9533_CR43","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/ATVBAHA.106.138743","volume":"27","author":"PJ Pussinen","year":"2007","unstructured":"Pussinen PJ, Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, et al. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007;27(6):1433\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"9533_CR44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.03600807","volume":"3","author":"CC Szeto","year":"2008","unstructured":"Szeto CC, Szeto CC, Kwan BC, Chow KM, Lai KB, Chung KY, et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2008;3(2):431\u20136.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"9533_CR45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/ATVBAHA.107.155606","volume":"28","author":"C Cuaz-P\u00e9rolin","year":"2008","unstructured":"Cuaz-P\u00e9rolin C, Billiet L, Baug\u00e9 E, Copin C, Scott-Algara D, Genze F, et al. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged. Arterioscler Thromb Vasc Biol. 2008;28(2):272\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"19","key":"9533_CR46","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.110.981365","volume":"122","author":"TH Malik","year":"2010","unstructured":"Malik TH, Cortini A, Carassiti D, Boyle JJ, Haskard DO, Botto M. The alternative pathway is critical for pathogenic complement activation in endotoxin- and diet-induced atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation. 2010;122(19):1948\u201356.","journal-title":"Circulation."},{"issue":"29","key":"9533_CR47","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0403249101","volume":"101","author":"KS Michelsen","year":"2004","unstructured":"Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, et al. Lack of toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci U S A. 2004;101(29):10679\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"9533_CR48","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015\u201325.","journal-title":"J Clin Invest"},{"issue":"3","key":"9533_CR49","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.numecd.2015.12.001","volume":"26","author":"M Herieka","year":"2016","unstructured":"Herieka M, Faraj TA, Erridge C. Reduced dietary intake of pro-inflammatory toll-like receptor stimulants favourably modifies markers of cardiometabolic risk in healthy men. Nutr Metab Cardiovasc Dis. 2016;26(3):194\u2013200.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"9533_CR50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1194\/jlr.M800156-JLR200","volume":"50","author":"S Ghoshal","year":"2009","unstructured":"Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 2009;50(1):90\u20137.","journal-title":"J Lipid Res"},{"issue":"5","key":"9533_CR51","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/ajcn\/86.5.1286","volume":"86","author":"C Erridge","year":"2007","unstructured":"Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr. 2007;86(5):1286\u201392.","journal-title":"Am J Clin Nutr"},{"issue":"9167","key":"9533_CR52","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","volume":"353","author":"J Niebauer","year":"1999","unstructured":"Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353(9167):1838\u201342.","journal-title":"Lancet."},{"issue":"8","key":"9533_CR53","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"PD CCani","year":"2009","unstructured":"CCani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58(8):1091\u2013103.","journal-title":"Gut."},{"issue":"Suppl 3","key":"9533_CR54","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/dom.12157","volume":"15","author":"R Burcelin","year":"2013","unstructured":"Burcelin R, Serino M, Chabo C, Garidou L, Pomi\u00e9 C, Courtney M, et al. Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes Obes Metab. 2013;15(Suppl 3):61\u201370.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"9533_CR55","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/emmm.201100159","volume":"3","author":"J Amar","year":"2011","unstructured":"Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Berm\u00fadez-Humar\u00e1n LG, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011;3(9):559\u201372.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"9533_CR56","doi-asserted-by":"publisher","first-page":"e54461","DOI":"10.1371\/journal.pone.0054461","volume":"8","author":"Jacques Amar","year":"2013","unstructured":"Amar J, Lange C, Payros G et al (2013) Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general populati- on: the D.E.S.I.R. study. PLoS ONE 8:e54461. https:\/\/doi.org\/10.1371\/journal.pone.0054461.","journal-title":"PLoS ONE"},{"issue":"3","key":"9533_CR57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro.2017.149","volume":"16","author":"JM Brown","year":"2018","unstructured":"Brown JM, Hazen SL. Microbial modulation of cardiovascular disease. Nat Rev Microbiol. 2018;16(3):171\u201381.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"9533_CR58","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576\u201385.","journal-title":"Nat Med"},{"issue":"1","key":"9533_CR59","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002314","volume":"9","author":"CL Organ","year":"2016","unstructured":"Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, et al. Choline diet and its gut microbe-derived metabolite, Trimethylamine N-oxide, exacerbate pressure overload-induced heart failure. Circ Heart Fail. 2016;9(1):e002314.","journal-title":"Circ Heart Fail"},{"issue":"7341","key":"9533_CR60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472(7341):57\u201363.","journal-title":"Nature."},{"issue":"3","key":"9533_CR61","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","volume":"10","author":"M Warrier","year":"2015","unstructured":"Warrier M, Shih DM, Burrows AC, Ferguson D, Gromovsky AD, Brown AL, et al. The TMAO-generating enzyme Flavin Monooxygenase 3 is a central regulator of cholesterol balance. Cell Rep. 2015;10(3):326\u201338.","journal-title":"Cell Rep"},{"issue":"1","key":"9533_CR62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu W, Gregory JC, Org E, Buffa JA, Gupta N, Wang Z, et al. Gut microbial metabolite TMAO enhances platelet Hyperreactivity and thrombosis risk. Cell. 2016;165(1):111\u201324.","journal-title":"Cell."},{"issue":"7","key":"9533_CR63","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, et al. Non-lethal inhibition of gut microbial Trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585\u201395.","journal-title":"Cell."},{"issue":"1","key":"9533_CR64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2049-2618-1-8","volume":"1","author":"M Vital","year":"2013","unstructured":"Vital M, Penton CR, Wang Q, Young VB, Antonopoulos DA, Sogin ML, et al. A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome. 2013;1(1):8.","journal-title":"Microbiome."},{"issue":"3","key":"9533_CR65","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/mol.115.102301","volume":"89","author":"D Bolognini","year":"2016","unstructured":"Bolognini D, Tobin AB, Milligan G, Moss CE. The pharmacology and function of receptors for short-chain fatty acids. Mol Pharmacol. 2016;89(3):388\u201398.","journal-title":"Mol Pharmacol"},{"issue":"12","key":"9533_CR66","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41564-018-0272-x","volume":"3","author":"K Kasahara","year":"2018","unstructured":"Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, et al. Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. Nat Microbiol. 2018;3(12):1461\u201371.","journal-title":"Nat Microbiol"},{"issue":"10","key":"9533_CR67","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","volume":"135","author":"FZ Marques","year":"2017","unstructured":"Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, et al. High-Fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964\u201377.","journal-title":"Circulation."},{"issue":"7612","key":"9533_CR68","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376\u201381.","journal-title":"Nature"},{"issue":"18","key":"9533_CR69","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","volume":"125","author":"S Cheng","year":"2012","unstructured":"Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125(18):2222\u201331.","journal-title":"Circulation."},{"issue":"4","key":"9533_CR70","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm.4057","volume":"22","author":"Cholsoon Jang","year":"2016","unstructured":"Jang C, Oh SF, Wada S, Rowe GC, Liu L, Chan MC, Rhee J, Hoshino A, Kim B, Ibrahim A, Baca LG, Kim E, Ghosh CC, Parikh SM, Jiang A, Chu Q, Forman DE, Lecker SH, Krishnaiah S, Rabinowitz JD, Weljie AM, Baur JA, Kasper DL, Arany Z. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med. 2016;22(4):421\u20136. https:\/\/doi.org\/10.1038\/nm.4057.","journal-title":"Nature Medicine"},{"issue":"4","key":"9533_CR71","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002157","volume":"11","author":"DK Tobias","year":"2018","unstructured":"Tobias DK, Lawler PR, Harada PH, Demler OV, Ridker PM, Manson JE, et al. Circulating branched-chain amino acids and incident cardiovascular disease in a prospective cohort of US women. Circ Genom Precis Med. 2018;11(4):e002157.","journal-title":"Circ Genom Precis Med"},{"issue":"4","key":"9533_CR72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.4057","volume":"22","author":"C Jang","year":"2016","unstructured":"Jang C, Oh SF, Wada S, Rowe GC, Liu L, Chan MC, et al. A branched-chain amino acid metabolite drives vascular fatty acid transport andcauses insulin resistance. Nat Med. 2016;22(4):421\u20136.","journal-title":"Nat Med"},{"issue":"7682","key":"9533_CR73","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, et al. A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature. 2017;551(7682):648\u201352.","journal-title":"Nature."},{"issue":"2","key":"9533_CR74","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","volume":"41","author":"M Venkatesh","year":"2014","unstructured":"Venkatesh M, Mukherjee S, Wang H, Li H, Sun K, Benechet AP, et al. Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4. Immunity. 2014;41(2):296\u2013310.","journal-title":"Immunity."},{"issue":"1","key":"9533_CR75","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41387-018-0046-9","volume":"8","author":"M Tuomainen","year":"2018","unstructured":"Tuomainen M, Lindstr\u00f6m J, Lehtonen M, Auriola S, Pihlajam\u00e4ki J, Peltonen M, et al. Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals. Nutr Diabetes. 2018 May;8(1):35.","journal-title":"Nutr Diabetes"},{"key":"9533_CR76","doi-asserted-by":"crossref","first-page":"46337","DOI":"10.1038\/srep46337","volume":"7","author":"VD de Mello","year":"2017","unstructured":"de Mello VD, Paananen J, Lindstr\u00f6m J, Lankinen MA, Shi L, Kuusisto J, et al. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish diabetes prevention study. Sci Rep. 2017;7:46337.","journal-title":"Sci Rep"},{"issue":"5","key":"9533_CR77","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jvs.2017.09.029","volume":"68","author":"CA Cason","year":"2018","unstructured":"Cason CA, Dolan KT, Sharma G, Tao M, Kulkarni R, Helenowski IB, et al. Plasma microbiome-modulated indole- and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes. J Vasc Surg. 2018;68(5):1552\u20131562.e7. https:\/\/doi.org\/10.1016\/j.jvs.2017.09.029.","journal-title":"J Vasc Surg"},{"issue":"33","key":"9533_CR78","doi-asserted-by":"crossref","first-page":"11508","DOI":"10.1021\/bi980087p","volume":"37","author":"Sharon Heath-Pagliuso","year":"1998","unstructured":"Heath-Pagliuso S, Rogers WJ, Tullis K, Seidel SD, Cenijn PH, Brouwer A, Denison MS. Activation of the Ah receptor by tryptophan and tryptophan metabolites. Biochemistry. 1998;37(33):11508\u201315.","journal-title":"Biochemistry"},{"issue":"8","key":"9533_CR79","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41591-018-0060-4","volume":"24","author":"Ludivine Laurans","year":"2018","unstructured":"Laurans L, Venteclef N, Haddad Y, Chajadine M, Alzaid F, Metghalchi S, et al. Genetic deficiency of indoleamine 2,3-dioxygenase promotes gutmicrobiota-mediated metabolic health.Nat Med. 2018;24:1113\u201320. https:\/\/doi.org\/10.1038\/s41591-018-0060-4.","journal-title":"Nature Medicine"},{"key":"9533_CR80","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcard.2015.03.413","volume":"189","author":"Simone J.P.M. Eussen","year":"2015","unstructured":"Eussen SJPM, Ueland PM, Vollset SE, Nyg\u00e5rd O, Midttun \u00d8, Sulo G, et al. Kynurenines as predictors of acute coronary events in the Hordaland health study. Int J Cardiol. 2015. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.413.","journal-title":"International Journal of Cardiology"},{"issue":"40","key":"9533_CR81","doi-asserted-by":"crossref","first-page":"10438","DOI":"10.1021\/acs.jafc.8b04102","volume":"66","author":"I Guti\u00e9rrez-D\u00edaz","year":"2018","unstructured":"Guti\u00e9rrez-D\u00edaz I, Fern\u00e1ndez-Navarro T, Salazar N, Bartolom\u00e9 B, Moreno-Arribas MV, L\u00f3pez P, et al. Could fecal Phenylacetic and Phenylpropionic acids be used as indicators of health status? J Agric Food Chem. 2018;66(40):10438\u201346.","journal-title":"J Agric Food Chem"},{"key":"9533_CR82","unstructured":"Lin CJ, Wu V, Wu PC, Wu CJ. Meta-analysis of the associations of p-Cresyl sulfate (PCS) and Indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients."},{"issue":"5","key":"9533_CR83","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1681\/ASN.2018060609","volume":"30","author":"B Opdebeeck","year":"2019","unstructured":"Opdebeeck B, Maudsley S, Azmi A, De Mar\u00e9 A, De Leger W, Meijers B, et al. Indoxyl sulfate and p-Cresyl sulfate promote vascular calcification and associate with glucose intolerance. J Am Soc Nephrol. 2019;30(5):751\u201366.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"9533_CR84","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.118.314642","volume":"124","author":"A Kurilshikov","year":"2019","unstructured":"Kurilshikov A, van den Munckhof ICL, Chen L, Bonder MJ, Schraa K, Rutten JHW, et al. Van Faassen M; LifeLines DEEP cohort study, BBMRI metabolomics consortium, Slagboom PE, Xavier RJ, Kuipers F, Hofker MH, Wijmenga C, Netea MG, Zhernakova A, Fu J. gut microbial associations to plasma metabolites linked to cardiovascular phenotypes and risk. Circ Res. 2019;124(12):1808\u201320.","journal-title":"Circ Res"},{"issue":"2","key":"9533_CR85","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241\u201359.","journal-title":"J Lipid Res"},{"issue":"7","key":"9533_CR86","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679\u201394.","journal-title":"Gastroenterology."},{"key":"9533_CR87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molmet.2018.01.005","volume":"9","author":"K Jadhav","year":"2018","unstructured":"Jadhav K, Xu Y, Xu Y, Li Y, Xu J, Zhu Y, et al. Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR. Mol Metab. 2018;9:131\u201340.","journal-title":"Mol Metab"},{"issue":"12","key":"9533_CR88","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.amjcard.2019.03.017","volume":"123","author":"A Alonso","year":"2019","unstructured":"Alonso A, Yu B, Sun YV, Chen LY, Loehr LR, O'Neal WT, et al. Serum metabolomics and incidence of atrial fibrillation (from the atherosclerosis risk in communities study). Am J Cardiol. 2019;123(12):1955\u201361.","journal-title":"Am J Cardiol"},{"issue":"9","key":"9533_CR89","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"Cristiane C.K. Mayerhofer","year":"2017","unstructured":"Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, et al. Increased secondary\/primary bile acid ratio in chronic heart failure. J Card Fail. 2017;23(9):666\u201371.","journal-title":"Journal of Cardiac Failure"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-019-09533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-019-09533-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-019-09533-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T19:37:05Z","timestamp":1607801825000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-019-09533-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9533"],"URL":"https:\/\/doi.org\/10.1007\/s11154-019-09533-9","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"14 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M.F. is co-inventor on pending patents held by INSERM Transfert, INSERM, University of Rome Tor Vergata, University of Girona and Imperial College on NAFLD diagnostics and has the right to receive royalty payments for inventions or discoveries related to NAFLD diagnostics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}